Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Acceleron completes target enrollment in phase 2 trial of Sotatercept in PAH
Image: Acceleron completes target enrollment in phase 2 trial of Sotatercept in pulmonary arterial hypertension. Photo: courtesy of burlesonmatthew from Pixabay.
Image: Acceleron completes target enrollment in phase 2 trial of Sotatercept in pulmonary arterial hypertension. Photo: courtesy of burlesonmatthew from Pixabay.